| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |